OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Piperine-Coated Gold Nanoparticles Alleviate Paraquat-Induced Neurotoxicity in Drosophila melanogaster
Saurabh Srivastav, Bibin G. Anand, Mahino Fatima, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 22, pp. 3772-3785
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Neurodegenerative Diseases: Implications of Environmental and Climatic Influences on Neurotransmitters and Neuronal Hormones Activities
Emmanuel Ayodeji Ayeni, Ahmad M. Aldossary, Daniel A. Ayejoto, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 12495-12495
Open Access | Times Cited: 56

Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease
Munire Aili, Kebing Zhou, Jun Zhan, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8605-8621
Open Access | Times Cited: 26

Fabricating Silver Nanoparticles with Antidiabetic d-Pinitol to Restrict Amyloid Formation of Insulin
Om Prakash Mahato, Kailash Prasad Prajapati, Masihuzzaman Ansari, et al.
ACS Applied Bio Materials (2025)
Closed Access | Times Cited: 1

Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease
Mir Hilal Ahmad, Mahino Fatima, Mansoor Ali, et al.
Neuropharmacology (2021) Vol. 201, pp. 108831-108831
Closed Access | Times Cited: 45

Therapeutic spectrum of piperine for clinical practice: a scoping review
Suraj Singh Yadav, Manish Kumar Singh, Sartaj Hussain, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 22, pp. 5813-5840
Closed Access | Times Cited: 30

Developmental neurotoxic effects of bisphenol A and its derivatives in Drosophila melanogaster
Jie Wang, Chunyan Wu, Xing Zhang, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 260, pp. 115098-115098
Open Access | Times Cited: 20

Medicinal Plants for Anti-neurodegenerative diseases in West Africa
Emmanuel Ayodeji Ayeni, Yuzhou Gong, Hao Yuan, et al.
Journal of Ethnopharmacology (2021) Vol. 285, pp. 114468-114468
Closed Access | Times Cited: 39

Neuroprotective Effects of Black Pepper and Its Bioactive Compounds in Age-Related Neurological Disorders
Rengasamy Balakrishnan, Shofiul Azam, In‐Su Kim, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 750-750
Open Access | Times Cited: 25

Integrated metabolomics and transcriptomics reveal the neuroprotective effect of nervonic acid on LPS-induced AD model mice
Xueqi Wang, Zhengdou Li, Xu Li, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115411-115411
Closed Access | Times Cited: 16

Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies
Ibukun O. Oresanya, İlkay Erdoğan Orhan
Current Drug Targets (2024) Vol. 25, Iss. 5, pp. 330-352
Closed Access | Times Cited: 5

Gold Nanoparticles in Parkinson’s Disease Therapy: A Focus on Plant-Based Green Synthesis
Tsenka Grancharova, Stanislava Simeonova, Bissera Pilicheva, et al.
Cureus (2024)
Open Access | Times Cited: 5

Targeting Lysozyme-Linked Amyloidosis through Piperine-Functionalized Gold Nanoparticles
Anubhuti Bhatia, N.C. Mishra, Kailash Prasad Prajapati, et al.
ACS Applied Bio Materials (2025)
Closed Access

Tryptophan self-assembly yields cytotoxic nanofibers containing amyloid-mimicking and cross-seeding competent conformers
Kailash Prasad Prajapati, Bibin G. Anand, Masihuzzaman Ansari, et al.
Nanoscale (2022) Vol. 14, Iss. 43, pp. 16270-16285
Closed Access | Times Cited: 18

Evidence of Anti-amyloid Characteristics of Plumbagin via Inhibition of Protein Aggregation and Disassembly of Protein Fibrils
Bibin G. Anand, Kailash Prasad Prajapati, Sampreeta Purohit, et al.
Biomacromolecules (2021) Vol. 22, Iss. 9, pp. 3692-3703
Closed Access | Times Cited: 22

Pleiotropic Nanostructures Built from l-Histidine Show Biologically Relevant Multicatalytic Activities
Kailash Prasad Prajapati, Shikha Mittal, Masihuzzaman Ansari, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 15, pp. 18268-18284
Closed Access | Times Cited: 2

Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseases
Anjali Bhosale, Gajanan Paul, Farhan Mazahir, et al.
OpenNano (2022) Vol. 9, pp. 100111-100111
Open Access | Times Cited: 11

Protective Effect of Quercetin against Paraquat-induced Brain Mitochondrial Disruption in Mice
Parisa Saberi-Hasanabadi, Reza Sedaghatnejad, Hamidreza Mohammadi
Current Drug Safety (2023) Vol. 19, Iss. 1, pp. 44-50
Closed Access | Times Cited: 6

Induction of oxidative stress and apoptosis in the injured brain: potential relevance to brain regeneration in zebrafish
Surendra Kumar Anand, Manas Ranjan Sahu, Amal Chandra Mondal
Molecular Biology Reports (2021) Vol. 48, Iss. 6, pp. 5099-5108
Open Access | Times Cited: 13

Age-related Mitochondrial Dysfunction in Parkinson's Disease: New Insights Into the Disease Pathology
Linchi Rani, Manas Ranjan Sahu, Amal Chandra Mondal
Neuroscience (2022) Vol. 499, pp. 152-169
Closed Access | Times Cited: 9

UPLC-Q-TOF/MS based serum and urine metabolomics strategy to analyze the mechanism of nervonic acid in treating Alzheimer’s disease
Ziyi Chen, Shu Liu, Hui Zhou, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 240, pp. 115930-115930
Closed Access | Times Cited: 5

Exploring environmental factors contributing to Parkinson’s disease in AfrAbian populations
Wael Mohamed
Academia Biology (2024) Vol. 2, Iss. 4
Closed Access | Times Cited: 1

Drosophila: A Model to Study the Pathogenesis of Parkinson’s Disease
Rahul, Yasir Hasan Siddique
CNS & Neurological Disorders - Drug Targets (2021) Vol. 21, Iss. 3, pp. 259-277
Closed Access | Times Cited: 10

Application of neurotoxin- and pesticide-induced animal models of Parkinson’s disease in the evaluation of new drug delivery systems
Yaquelyn Casanova, Sofı́a Negro, Emilia Barcia
Acta Pharmaceutica (2021) Vol. 72, Iss. 1, pp. 35-58
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top